RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
9 Meters Biopharma Stock

9 Meters Biopharma ROCE 2024

9 Meters Biopharma ROCE

-17.5

Ticker

NMTR

ISIN

US6544051096

WKN

A2P362

In 2024, 9 Meters Biopharma's return on capital employed (ROCE) was -17.5, a 2,200.16% increase from the -0.76 ROCE in the previous year.

9 Meters Biopharma Aktienanalyse

What does 9 Meters Biopharma do?

9 Meters Biopharma Inc is a company that specializes in researching, developing, and marketing innovative therapeutic treatment options for various chronic diseases. Founded in 2010, the company has since become a major player in the biopharmaceutical drug development industry. The main goal of 9 Meters Biopharma is to provide new and effective treatment options to patients suffering from chronic diseases. The company focuses on the areas of gastroenterology, oncology, autoimmune diseases, and rare diseases. Its business model is based on identifying promising drug candidates and conducting clinical trials to prove the effectiveness and safety of the drugs. Once a drug is successfully developed, the company focuses on marketing and distributing the medication. One of the company's key products is the drug NMIL1701, which is developed for the treatment of patients with celiac disease. The medication targets the breakdown of gluten, which is present in many foods and can cause an inappropriate immune response and chronic inflammation in the intestines of people with celiac disease. Additionally, the company is currently developing medications for the treatment of ulcerative colitis, Crohn's disease, and pancreatitis. It is also researching the development of drugs for the treatment of various cancers and autoimmune diseases, including multiple sclerosis, lupus, and rheumatoid arthritis. Another important aspect of 9 Meters Biopharma's activities is collaborating with other companies and organizations to accelerate and improve drug development. The company works with various academic institutions and research organizations to jointly work on the development of new therapies. Overall, 9 Meters Biopharma Inc has established itself as a dynamic and innovative company in the biopharmaceutical landscape. With its strong focus on the development of novel therapies and collaboration with other organizations, the company is likely to continue playing a major role in improving healthcare and treating chronic diseases. 9 Meters Biopharma ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling 9 Meters Biopharma's Return on Capital Employed (ROCE)

9 Meters Biopharma's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing 9 Meters Biopharma's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

9 Meters Biopharma's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in 9 Meters Biopharma’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about 9 Meters Biopharma stock

What is the ROCE (Return on Capital Employed) of 9 Meters Biopharma this year?

The ROCE of 9 Meters Biopharma is -17.5 undefined this year.

How has the ROCE (Return on Capital Employed) of 9 Meters Biopharma developed compared to the previous year?

The ROCE of 9 Meters Biopharma has increased by 2,200.16% increased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of 9 Meters Biopharma?

A high Return on Capital Employed (ROCE) indicates that 9 Meters Biopharma has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of 9 Meters Biopharma?

A low ROCE (Return on Capital Employed) can indicate that 9 Meters Biopharma has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from 9 Meters Biopharma impact the company?

An increase in the ROCE of 9 Meters Biopharma can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of 9 Meters Biopharma affect the company?

A decrease in ROCE of 9 Meters Biopharma can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of 9 Meters Biopharma?

Some factors that can affect 9 Meters Biopharma's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of 9 Meters Biopharma so important for investors?

The ROCE of 9 Meters Biopharma is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can 9 Meters Biopharma take to improve the ROCE?

To improve the ROCE, 9 Meters Biopharma can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does 9 Meters Biopharma pay?

Over the past 12 months, 9 Meters Biopharma paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, 9 Meters Biopharma is expected to pay a dividend of 0 USD.

What is the dividend yield of 9 Meters Biopharma?

The current dividend yield of 9 Meters Biopharma is .

When does 9 Meters Biopharma pay dividends?

9 Meters Biopharma pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of 9 Meters Biopharma?

9 Meters Biopharma paid dividends every year for the past 0 years.

What is the dividend of 9 Meters Biopharma?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is 9 Meters Biopharma located?

9 Meters Biopharma is assigned to the 'Health' sector.

Wann musste ich die Aktien von 9 Meters Biopharma kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of 9 Meters Biopharma from 11/17/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/17/2024.

When did 9 Meters Biopharma pay the last dividend?

The last dividend was paid out on 11/17/2024.

What was the dividend of 9 Meters Biopharma in the year 2023?

In the year 2023, 9 Meters Biopharma distributed 0 USD as dividends.

In which currency does 9 Meters Biopharma pay out the dividend?

The dividends of 9 Meters Biopharma are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von 9 Meters Biopharma

Our stock analysis for 9 Meters Biopharma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of 9 Meters Biopharma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.